STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

CNST CONSTELLATION PHARMACEUTICALS INCORPORATED StockScouter® Report

4

StockScouter® Score

CONSTELLATION PHARMACEUTICALS INCORPORATED, a small cap company in the healthcare sector, is expected to slightly underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The multi-period measure of relative price change and consistency is well above average. Positive
  • The 50-day moving average for CNST is significantly above its 200-day moving average. Positive

 

Concerns

  • Two or more executives, directors or major shareholders sold a large number of shares recently. Very negative
  • One or more analysts has modestly decreased quarterly earnings estimates for CNST. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 100% done.
Progress: 40% done.
Low
High

Core Model Grades

C
F
N/A
A

Previous Ratings

3
3
4